| Autor: |
P J, Neumann, E A, Sandberg, C M, Bell, P W, Stone, R H, Chapman |
| Rok vydání: |
2000 |
| Předmět: |
|
| Zdroj: |
Health affairs (Project Hope). 19(2) |
| ISSN: |
0278-2715 |
| Popis: |
The argument that prescription drugs are cost-effective has been made both by the pharmaceutical industry to support rising drug prices and expenditures, and by advocates of expanded drug coverage for elderly and low-income persons. A new database of 228 published cost-utility analyses sheds light on the issue. According to published data, some drugs do save money or are cost-effective, but the issue depends critically on the context in which the drug is used and the intervention with which it is compared. Cost-utility analyses funded by the drug industry tend to report more favorable results than do those funded by nonindustry sources. Cost-effectiveness analysis can help policymakers to determine whether drugs and other interventions offer value for money. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
